Centene Corp

Centene Corp (CNC) Stock Analysis

$70.810

+2.252 (+3.18%)At close

Loading chart…
High
70.970
Open
69.070
VWAP
70.23
Volume
3.39M
Mkt Cap
35.95B
Low
68.900
Amount
238.20M
EV/EBITDA, TTM
3.04

Centene Corporation is a healthcare company. It provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.

AI analysis of Centene Corp (CNC)

Buy

Centene Corp (CNC) is a good buy right now, trading at $69.16 with a forward P/E ratio of 11.22, indicating potential for growth. The stock has shown strong momentum, with a 5-day change of +5.81% and a year-to-date change of +65.53%. However, there is a risk of volatility with the recent negative earnings surprises, including a net loss of $13.50 per share in Q3 2025, which may affect investor sentiment.

Analyst Ratings (17)

-39.18% Downside
Buy
12 Buy
5 Hold
0 Sell
Current: 70.81
Low
32.00
Average
43.07
High
59.00

BofA

2026-09-11

Price Target

$80

Buy

Argus

2026-08-11

Price Target

$80

Buy

JPMorgan

2026-08-04

Price Target

$67

Neutral

Bernstein

2026-08-03

Price Target

$79

Outperform

Morgan Stanley

2026-07-29

Price Target

$66

Equal Weight

Valuation Metrics

The current forward P/E ratio for Centene Corp (CNC) is 11.22, compared to its 5-year average forward P/E of 12.58.

Forward P/E

Fair
5Y Average P/E
12.58
Current P/E
11.22
Overvalued
15.61
Undervalued
9.55

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
8.34
Current EV/EBITDA
3.04
Overvalued
13.77
Undervalued
2.90

Forward P/S

Fair
5Y Average P/S
0.23
Current P/S
0.18
Overvalued
0.32
Undervalued
0.14

Alphio AI Price Scenarios for CNC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CNC

$59.37

Scenario price

B

Base

Base · 50%CNC

$55.90

Scenario price

B

Bear

Bear · 25%CNC

$43.97

Scenario price

Whales holding CNC

S

Scharf Investments, LLC

+ HoldingCNC

+10.28%

3M Return

A

Acadian Asset Management LLC

+ HoldingCNC

+9.33%

3M Return

Q

Quantbot Technologies, LP

+ HoldingCNC

+8.38%

3M Return

I

IEQ Capital, LLC

+ HoldingCNC

+7.59%

3M Return

K

Kopernik Global Investors, LLC

+ HoldingCNC

+4.71%

3M Return

J

Jacobs Levy Equity Management Inc

+ HoldingCNC

+4.65%

3M Return

CNC FAQ — answered by Alphio AI

Centene Corporation is a healthcare company. It provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Centene Corp (CNC) is a good buy right now, trading at $69.16 with a forward P/E ratio of 11.22, indicating potential for growth. The stock has shown strong momentum, with a 5-day change of +5.81% and a year-to-date change of +65.53%. However, there is a risk of volatility with the recent negative earnings surprises, including a net loss of $13.50 per share in Q3 2025, which may affect investor sentiment.

17 analysts cover CNC: 12 rate it Buy, 5 Hold and 0 Sell. The average price target is 43.07.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading